Raaj medisafe India Limited successfully conducted its Extra Ordinary General Meeting on January 20, 2026, through video conferencing, addressing crucial capital structure decisions and corporate governance matters. The meeting commenced at 4:00 PM and concluded at 4:27 PM, with e-voting extending until 4:42 PM.

Meeting Structure and Governance

The EGM maintained proper regulatory compliance with requisite quorum present as per the Companies Act, 2013 provisions. The Chairman declared the meeting in order and appointed Mr. Manish Maheshwari as scrutinizer for both remote e-voting and e-voting during the meeting. The agenda items were based on the notice dated December 23, 2025, convening the Extra Ordinary General Meeting.

Key Resolutions Approved

The meeting addressed three significant business items that will impact the company's capital structure and operational flexibility:

Equity Share Issuance Details

The company approved the issuance of 32,75,000 equity shares of ₹10.00 face value each for cash at a premium of ₹45.00 per share through preferential allotment. This preferential allotment targets a select group of non-promoter persons, representing a significant capital raising initiative.

Shareholder Engagement and Communication

The Chairman facilitated shareholder participation by inviting speakers and addressing queries received from shareholders. The company emphasized its commitment to transparent communication by requesting shareholders to submit additional queries through the official email provided on the company website for comprehensive responses.

Next Steps and Documentation

The company indicated that detailed results of remote e-voting and e-voting conducted during the EGM will be forwarded separately upon declaration. This follows standard corporate governance practices for maintaining transparency in shareholder voting processes and ensuring proper documentation of meeting outcomes.

Raaj Medisafe India Limited has formally disclosed its acquisition of Fabrizo Industries Private Limited under SEBI Listing Regulations. The company filed the disclosure on December 23, 2025, providing comprehensive details about the strategic acquisition that forms part of its ₹43.00 crore expansion plan.

Acquisition Details and Strategic Rationale

The acquisition involves purchasing the plant, machinery, and related business operations of Fabrizo Industries Private Limited, located at Plot Nos. 46-50, Mapusa Industrial Estate, near St. Xaviers College, Bardez, Mapusa, Goa. The total consideration for the acquisition amounts to ₹28.00 crores in cash.

The proposed acquisition is expected to strengthen the company's product portfolio and broaden its customer base, thereby enhancing its position in the alco-bev packaging industry.

Target Company Background and Performance

Fabrizo Industries, incorporated on July 3, 2009, is engaged in manufacturing alco-bev closures with principal business customers in the alcoholic beverage industry. The company has demonstrated consistent revenue performance over recent years.

Complete Expansion Framework

The Fabrizo acquisition represents a significant component of Raaj Medisafe's broader expansion strategy. The board had previously approved a comprehensive investment plan totaling ₹43.00 crores.

Fundraising and Corporate Actions

To support the expansion initiatives, the board approved raising funds up to ₹18.01 crores through preferential allotment to select non-promoter investors. The company has also scheduled an extraordinary general meeting to address critical business items including authorized capital increase from ₹15.00 crores to ₹18.00 crores.

The acquisition does not involve any related party transactions, and no governmental or regulatory approvals are required for completion. The transaction is expected to be completed subject to fulfillment of closing conditions, positioning Raaj Medisafe for enhanced growth in the packaging materials and alco-bev closures segments.